Long-term efficacy and safety of rabeprazole in patients taking low-dose aspirin with a history of peptic ulcers: a phase 2/3, randomized, parallel-group, multicenter, extension clinical trial

A 24-week, double-blind, clinical trial of rabeprazole for the prevention of recurrent peptic ulcers caused by low-dose aspirin (LDA) has been reported, but trials for longer than 24 weeks have not been reported. The aim of this study is to assess the long-term efficacy and safety of rabeprazole for...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Biochem Nutr
Autors principals: Fujishiro, Mitsuhiro, Higuchi, Kazuhide, Kato, Mototsugu, Kinoshita, Yoshikazu, Iwakiri, Ryuichi, Watanabe, Toshio, Takeuchi, Toshihisa, Sugisaki, Nobuyuki, Okada, Yasushi, Ogawa, Hisao, Arakawa, Tetsuo, Fujimoto, Kazuma
Format: Artigo
Idioma:Inglês
Publicat: the Society for Free Radical Research Japan 2015
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4454079/
https://ncbi.nlm.nih.gov/pubmed/26060354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3164/jcbn.15-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars